ARGINASE INHIBITORS AND METHODS OF USE

or a pharmaceutically acceptable salt thereof, compositions containing these compounds, and methods of their use for the treatment and diagnosis of conditions characterized by upregulation of arginase, abnormally high arginase activity, or by abnormally low nitric oxide synthase activity.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHRISTIANSON David W, OLSON Gary Lee, COLASANTI Andrew Vargha, POTTORF Richard Scott, TOMCZUK Bruce Edward
Format: Patent
Sprache:eng ; slv
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHRISTIANSON David W
OLSON Gary Lee
COLASANTI Andrew Vargha
POTTORF Richard Scott
TOMCZUK Bruce Edward
description or a pharmaceutically acceptable salt thereof, compositions containing these compounds, and methods of their use for the treatment and diagnosis of conditions characterized by upregulation of arginase, abnormally high arginase activity, or by abnormally low nitric oxide synthase activity.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI2389352TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI2389352TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI2389352TT13</originalsourceid><addsrcrecordid>eNrjZFBzDHL39HMMdlXw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgNduVhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHBnkbGFpbGpkYhIYbGxKgBAL2XI-E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARGINASE INHIBITORS AND METHODS OF USE</title><source>esp@cenet</source><creator>CHRISTIANSON David W ; OLSON Gary Lee ; COLASANTI Andrew Vargha ; POTTORF Richard Scott ; TOMCZUK Bruce Edward</creator><creatorcontrib>CHRISTIANSON David W ; OLSON Gary Lee ; COLASANTI Andrew Vargha ; POTTORF Richard Scott ; TOMCZUK Bruce Edward</creatorcontrib><description>or a pharmaceutically acceptable salt thereof, compositions containing these compounds, and methods of their use for the treatment and diagnosis of conditions characterized by upregulation of arginase, abnormally high arginase activity, or by abnormally low nitric oxide synthase activity.</description><language>eng ; slv</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190830&amp;DB=EPODOC&amp;CC=SI&amp;NR=2389352T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190830&amp;DB=EPODOC&amp;CC=SI&amp;NR=2389352T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHRISTIANSON David W</creatorcontrib><creatorcontrib>OLSON Gary Lee</creatorcontrib><creatorcontrib>COLASANTI Andrew Vargha</creatorcontrib><creatorcontrib>POTTORF Richard Scott</creatorcontrib><creatorcontrib>TOMCZUK Bruce Edward</creatorcontrib><title>ARGINASE INHIBITORS AND METHODS OF USE</title><description>or a pharmaceutically acceptable salt thereof, compositions containing these compounds, and methods of their use for the treatment and diagnosis of conditions characterized by upregulation of arginase, abnormally high arginase activity, or by abnormally low nitric oxide synthase activity.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBzDHL39HMMdlXw9PPwdPIM8Q8KVnD0c1HwdQ3x8HcJVvB3UwgNduVhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHBnkbGFpbGpkYhIYbGxKgBAL2XI-E</recordid><startdate>20190830</startdate><enddate>20190830</enddate><creator>CHRISTIANSON David W</creator><creator>OLSON Gary Lee</creator><creator>COLASANTI Andrew Vargha</creator><creator>POTTORF Richard Scott</creator><creator>TOMCZUK Bruce Edward</creator><scope>EVB</scope></search><sort><creationdate>20190830</creationdate><title>ARGINASE INHIBITORS AND METHODS OF USE</title><author>CHRISTIANSON David W ; OLSON Gary Lee ; COLASANTI Andrew Vargha ; POTTORF Richard Scott ; TOMCZUK Bruce Edward</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI2389352TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2019</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHRISTIANSON David W</creatorcontrib><creatorcontrib>OLSON Gary Lee</creatorcontrib><creatorcontrib>COLASANTI Andrew Vargha</creatorcontrib><creatorcontrib>POTTORF Richard Scott</creatorcontrib><creatorcontrib>TOMCZUK Bruce Edward</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHRISTIANSON David W</au><au>OLSON Gary Lee</au><au>COLASANTI Andrew Vargha</au><au>POTTORF Richard Scott</au><au>TOMCZUK Bruce Edward</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARGINASE INHIBITORS AND METHODS OF USE</title><date>2019-08-30</date><risdate>2019</risdate><abstract>or a pharmaceutically acceptable salt thereof, compositions containing these compounds, and methods of their use for the treatment and diagnosis of conditions characterized by upregulation of arginase, abnormally high arginase activity, or by abnormally low nitric oxide synthase activity.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; slv
recordid cdi_epo_espacenet_SI2389352TT1
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ARGINASE INHIBITORS AND METHODS OF USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T21%3A57%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHRISTIANSON%20David%20W&rft.date=2019-08-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI2389352TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true